Prophase Labs Stock Performance
| PRPH Stock | USD 0.20 0.01 5.26% |
The company holds a Beta of -2.15, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning ProPhase Labs are expected to decrease by larger amounts. On the other hand, during market turmoil, ProPhase Labs is expected to outperform it. At this point, ProPhase Labs has a negative expected return of -4.7%. Please make sure to check ProPhase Labs' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if ProPhase Labs performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days ProPhase Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2026. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Last Split Factor 1:10 | Dividend Date 2022-06-03 | Ex Dividend Date 2022-05-24 | Last Split Date 2025-12-22 |
1 | How ProPhase Labs Inc. stock reacts to job market data - 2025 Technical Overview Real-Time Stock Movement Alerts - newser.com | 11/04/2025 |
2 | ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals | 11/17/2025 |
3 | ProPhase Labs reports Q3 EPS vs. last year PRPH | 11/19/2025 |
4 | ProPhase Labs signals 50M net collection target and strategic initiatives as Crown Medical litigation advances - MSN | 11/21/2025 |
5 | Join ProPhase Labs Exclusive Live Investor Webinar and QA Session on December 1 | 11/26/2025 |
6 | Prophase Labs Implements Reverse Stock Split - TipRanks | 12/12/2025 |
7 | How ProPhase Labs Inc. stock compares to market leaders - July 2025 Summary Risk Managed Trade Strategies - | 12/18/2025 |
8 | ProPhase Labs Stock Price, Quote, News History - Benzinga | 12/26/2025 |
9 | ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value | 01/05/2026 |
10 | ProPhase Labs announces proposed reverse merger with ABL - MSN | 01/13/2026 |
| Begin Period Cash Flow | 1.6 M | |
| Total Cashflows From Investing Activities | 2.4 M |
ProPhase Labs Relative Risk vs. Return Landscape
If you would invest 500.00 in ProPhase Labs on October 17, 2025 and sell it today you would lose (480.00) from holding ProPhase Labs or give up 96.0% of portfolio value over 90 days. ProPhase Labs is currently does not generate positive expected returns and assumes 9.0623% risk (volatility on return distribution) over the 90 days horizon. In different words, 81% of stocks are less volatile than ProPhase, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ProPhase Labs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ProPhase Labs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ProPhase Labs, and traders can use it to determine the average amount a ProPhase Labs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.5183
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PRPH |
Based on monthly moving average ProPhase Labs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ProPhase Labs by adding ProPhase Labs to a well-diversified portfolio.
ProPhase Labs Fundamentals Growth
ProPhase Stock prices reflect investors' perceptions of the future prospects and financial health of ProPhase Labs, and ProPhase Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ProPhase Stock performance.
| Return On Equity | -2.2 | ||||
| Return On Asset | -0.23 | ||||
| Operating Margin | (5.40) % | ||||
| Current Valuation | 8.12 M | ||||
| Shares Outstanding | 4.19 M | ||||
| Price To Earning | 6.59 X | ||||
| Price To Book | 0.12 X | ||||
| Price To Sales | 0.15 X | ||||
| Revenue | 6.77 M | ||||
| Gross Profit | 987 K | ||||
| EBITDA | (32.34 M) | ||||
| Net Income | (49.52 M) | ||||
| Cash And Equivalents | 27.5 M | ||||
| Cash Per Share | 1.72 X | ||||
| Total Debt | 24.57 M | ||||
| Debt To Equity | 0.19 % | ||||
| Current Ratio | 4.20 X | ||||
| Book Value Per Share | 1.65 X | ||||
| Cash Flow From Operations | (17.54 M) | ||||
| Earnings Per Share | (19.80) X | ||||
| Market Capitalization | 757.17 K | ||||
| Total Asset | 63.2 M | ||||
| Retained Earnings | (58.39 M) | ||||
| Working Capital | (1.5 M) | ||||
| Current Asset | 9.73 M | ||||
| Current Liabilities | 6.25 M | ||||
About ProPhase Labs Performance
By evaluating ProPhase Labs' fundamental ratios, stakeholders can gain valuable insights into ProPhase Labs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ProPhase Labs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ProPhase Labs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 69.33 | 131.75 | |
| Return On Tangible Assets | (1.27) | (1.21) | |
| Return On Capital Employed | (1.43) | (1.36) | |
| Return On Assets | (0.97) | (0.92) | |
| Return On Equity | (8.35) | (7.93) |
Things to note about ProPhase Labs performance evaluation
Checking the ongoing alerts about ProPhase Labs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ProPhase Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ProPhase Labs generated a negative expected return over the last 90 days | |
| ProPhase Labs has high historical volatility and very poor performance | |
| ProPhase Labs has some characteristics of a very speculative penny stock | |
| ProPhase Labs has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 6.77 M. Net Loss for the year was (49.52 M) with profit before overhead, payroll, taxes, and interest of 987 K. | |
| ProPhase Labs currently holds about 27.5 M in cash with (17.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: Can Synlogic Inc. stock beat analyst upgrades - Weekly Investment Summary Community Consensus Picks - ulpravda.ru |
- Analyzing ProPhase Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ProPhase Labs' stock is overvalued or undervalued compared to its peers.
- Examining ProPhase Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ProPhase Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of ProPhase Labs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ProPhase Labs' stock. These opinions can provide insight into ProPhase Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ProPhase Stock analysis
When running ProPhase Labs' price analysis, check to measure ProPhase Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProPhase Labs is operating at the current time. Most of ProPhase Labs' value examination focuses on studying past and present price action to predict the probability of ProPhase Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProPhase Labs' price. Additionally, you may evaluate how the addition of ProPhase Labs to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |